Melanoma (Skin) Clinical Trials
There are 13 registered clinical trials for Melanoma (Skin) in the TrialLens index.
Trials (13)
- Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma. N/A · University of Sydney
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma Phase 1 · Dartmouth-Hitchcock Medical Center
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma Phase 2 · Memorial Sloan Kettering Cancer Center
- Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo N/A · Momentum Data
- Investigation of a Behavioral Substitute for Sunbathing Phase 1/2 · University of Massachusetts, Worcester
- Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery Phase 2 · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma N/A · Institut de Cancérologie de Lorraine
- Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma Phase 2 · National Cancer Institute (NCI)
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma Phase 1/2 · Jonsson Comprehensive Cancer Center
- Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors Phase 1 · University of Rochester
- Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma Phase 2 · Eastern Cooperative Oncology Group
- Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors Phase 1 · Children's Oncology Group
- Boron Neutron Capture Therapy in Treating Patients With Melanoma Phase 2 · Beth Israel Deaconess Medical Center
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.